JP2016505036A - Ｖｓｎ１６の結晶形態 - Google Patents

Ｖｓｎ１６の結晶形態 Download PDF

Info

Publication number
JP2016505036A
JP2016505036A JP2015553165A JP2015553165A JP2016505036A JP 2016505036 A JP2016505036 A JP 2016505036A JP 2015553165 A JP2015553165 A JP 2015553165A JP 2015553165 A JP2015553165 A JP 2015553165A JP 2016505036 A JP2016505036 A JP 2016505036A
Authority
JP
Japan
Prior art keywords
compound
crystalline form
crystalline
treatment
form according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015553165A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016505036A5 (https=
Inventor
デイヴィッド セルウッド
デイヴィッド セルウッド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canbex Therapeutics Ltd
Original Assignee
Canbex Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canbex Therapeutics Ltd filed Critical Canbex Therapeutics Ltd
Publication of JP2016505036A publication Critical patent/JP2016505036A/ja
Publication of JP2016505036A5 publication Critical patent/JP2016505036A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/68—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/69—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2015553165A 2013-01-18 2014-01-17 Ｖｓｎ１６の結晶形態 Pending JP2016505036A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1300903.0A GB201300903D0 (en) 2013-01-18 2013-01-18 Crystalline Form
GB1300903.0 2013-01-18
PCT/GB2014/050127 WO2014111720A1 (en) 2013-01-18 2014-01-17 Crystalline form of vsn16

Publications (2)

Publication Number Publication Date
JP2016505036A true JP2016505036A (ja) 2016-02-18
JP2016505036A5 JP2016505036A5 (https=) 2017-02-23

Family

ID=47843537

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015553165A Pending JP2016505036A (ja) 2013-01-18 2014-01-17 Ｖｓｎ１６の結晶形態

Country Status (9)

Country Link
US (1) US9682924B2 (https=)
EP (1) EP2945619B1 (https=)
JP (1) JP2016505036A (https=)
CN (1) CN105142626A (https=)
CA (1) CA2897524A1 (https=)
GB (1) GB201300903D0 (https=)
NZ (1) NZ630795A (https=)
RU (1) RU2015134560A (https=)
WO (1) WO2014111720A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3256112A1 (en) * 2015-02-13 2017-12-20 Canbex Therapeutics Limited Compounds for treating disorders associated with bk channel modulation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007523150A (ja) * 2004-02-20 2007-08-16 ユーシーエル・バイオメディカ・ピーエルシー 調節物質
WO2010116116A1 (en) * 2009-03-06 2010-10-14 Ucl Business Plc Process for preparing carboxylic acid amides useful in the treatment of muscular disorders

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007523150A (ja) * 2004-02-20 2007-08-16 ユーシーエル・バイオメディカ・ピーエルシー 調節物質
WO2010116116A1 (en) * 2009-03-06 2010-10-14 Ucl Business Plc Process for preparing carboxylic acid amides useful in the treatment of muscular disorders

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BRITISH JOURNAL OF PHARMACOLOGY, vol. 152, no. 5, JPN7018000161, 2007, pages 751 - 764, ISSN: 0003892182 *
仲井由宣=花野学 編, 新製剤学, vol. 第１版第２刷, JPN6016032041, 25 April 1984 (1984-04-25), JP, pages 104 - 217, ISSN: 0003892183 *
塩路雄作, 固形製剤の製造技術, vol. 普及版第１刷, JPN6016031894, 27 January 2003 (2003-01-27), JP, pages 9 - 14, ISSN: 0003892184 *
平山令明 編著, 有機化合物結晶作製ハンドブック−原理とノウハウ−, JPN6016031902, 25 July 2008 (2008-07-25), JP, pages 37 - 84, ISSN: 0003892185 *
社団法人日本化学会 編, 第４版 実験化学講座１ 基本操作Ｉ, vol. 第２刷, JPN6016031896, 5 April 1996 (1996-04-05), JP, pages 184 - 186, ISSN: 0003892186 *

Also Published As

Publication number Publication date
WO2014111720A1 (en) 2014-07-24
GB201300903D0 (en) 2013-03-06
EP2945619B1 (en) 2019-05-08
RU2015134560A (ru) 2017-02-28
US20150353476A1 (en) 2015-12-10
US9682924B2 (en) 2017-06-20
CA2897524A1 (en) 2014-07-24
CN105142626A (zh) 2015-12-09
EP2945619A1 (en) 2015-11-25
NZ630795A (en) 2016-07-29

Similar Documents

Publication Publication Date Title
TWI682929B (zh) 一種阿片樣物質受體（mor）激動劑的鹽、其富馬酸鹽i晶型及製備方法
US20190315736A1 (en) Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate
TWI799431B (zh) RORγ抑制劑
JP5710490B2 (ja) （ｒ）−５−（（ｅ）−２−（ピロリジン−３−イルビニル）ピリミジンの合成および新規の塩形態
US20170267633A1 (en) Novel crystalline arylalkylamine compound and process for producing the same
TW201718516A (zh) 組蛋白去乙醯酶抑制劑之晶形
KR101804749B1 (ko) 히스타민 ｈ3 수용체 길항제의 신규 푸마레이트 염
JP2016505036A (ja) Ｖｓｎ１６の結晶形態
KR102659846B1 (ko) 치환된-퀴녹살린-유형 브리지된-피페리딘 화합물의 다형체 형태
JP2018024636A (ja) ［（２ｒ，３ｓ，４ｒ，５ｒ）−５−（６−（シクロペンチルアミノ）−９ｈ−プリン−９−イル）−３，４−ジヒドロキシテトラヒドロフラン−２−イル］メチルナイトレートの無水多形体及びその製造方法
JP5968881B2 (ja) カルシウム模倣化合物の新規多形
US11208382B2 (en) Entinostat-containing compound, crystal form of compound thereof, and preparation method therefor and pharmaceutical composition thereof
US12054457B2 (en) Polymorphs of (2S,5R)-5-(2-chlorophenyl)-1-(2′-methoxy-[1,1′-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid and preparation processes thereof
US9981912B2 (en) Cocrystal of lorcaserin, preparation methods, pharmaceutical compositions and uses thereof
US20240294472A1 (en) Polymorphs of (2s,5r)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid and preparation processes thereof
TW202016099A (zh) 一種鴉片類物質受體激動劑的結晶形式及製備方法
CN104936947A (zh) 氯卡色林盐及其晶体、其制备方法和用途
KR20260003055A (ko) 에베나마이드의 결정형
KR20250065875A (ko) 네피카스타트 산 부가 염의 다형체 형태, 이의 제조 방법 및 이의 용도
EP4615835A1 (en) Solid state forms of belumosudil and processes for preparation thereof
JP2021505602A (ja) 腎外髄質カリウムチャネル阻害剤の結晶形およびその調製方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170116

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170116

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20171213

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180123

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180410

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20181004